CenterStar Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-7,695
Closed -$1.04M – 306
2023
Q2
$1.04M Buy
+7,695
New +$1.13M 0.11% 119
2022
Q1
– Hold
0
– – – 572
2021
Q4
– Hold
0
– – – 315
2021
Q1
– Hold
0
– – – 481
2020
Q4
– Hold
0
– – – 578
2020
Q3
– Hold
0
– – – 314
2020
Q2
– Hold
0
– – – 449
2018
Q4
– Hold
0
– – – 52
2018
Q3
– Hold
0
– – – 42

Other funds holding ABBV

CenterStar Asset Management's ABBV Position: Q3 2023 in Review

CenterStar Asset Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 7,695 shares — an estimated $1.04M sold.

CenterStar Asset Management first reported a position in ABBV in Q2 2023 and held it in 1 quarter. The position peaked at $1.04M in Q2 2023. 3,112 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • CenterStar Asset Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • CenterStar Asset Management sold 7,695 AbbVie shares in Q3 2023, an estimated $1.04M.
  • CenterStar Asset Management first reported a position in AbbVie in Q2 2023 and held it in 1 quarter.
  • CenterStar Asset Management's AbbVie position peaked at $1.04M in Q2 2023.
  • 3,112 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on CenterStar Asset Management's 13F filing for Q3 2023, filed 19 Oct 2023.